Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Clinical trial NCT00211471 · TERMINATED

Trial details

NCT number: NCT00211471
Sponsor: Manhattan Eye, Ear & Throat Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Diabetic Retinopathy Central Retinal Vein Occlusion Chronic Inflammation Infectious Diseases

Start date: 2002-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.